Vaccine. 2002 Nov 22;21(1-2):7-14.

A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

Source

Department of Infectious Disease Immunology, Statens Serum Institut, Artillerivej 5, 2300, Copenhagen S, Denmark.

Abstract

The protection afforded by the currently available tuberculosis vaccine, bacillus Calmette-Guérin (BCG) is insufficient and new vaccine strategies are urgently needed. Progress in our understanding of the immunological deficits of BCG combined with novel knowledge on genetics of mycobacteria has paved the way for promising new vaccine strategies. These include recombinant modified BCG vaccines, attenuated strains of Mycobacterium tuberculosis, and various non-live candidates such as DNA and subunit vaccines. Decisive for transforming technical progress into a novel tuberculosis (TB) vaccine strategy is the recent advance in our understanding of the failure of BCG in the third world and the interaction between this vaccine and environmental mycobacteria.

PMID:: 12443657; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Tuberculosis - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. [Curr Pharm Biotechnol. 2001]
Review Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis.
Mustafa AS. Curr Pharm Biotechnol. 2001 Jun; 2(2):157-73.
Review Recent developments in tuberculosis vaccines. [Curr Opin Infect Dis. 2005]
Review Recent developments in tuberculosis vaccines.
Haile M, Källenius G. Curr Opin Infect Dis. 2005 Jun; 18(3):211-5.
Review [Novel vaccines against M. tuberculosis]. [Kekkaku. 2006]
Review [Novel vaccines against M. tuberculosis].
Okada M. Kekkaku. 2006 Dec; 81(12):745-51.
[Recent progress in mycobacteriology]. [Kekkaku. 2007]
[Recent progress in mycobacteriology].
Okada M, Kobayashi K. Kekkaku. 2007 Oct; 82(10):783-99.
New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex. [Immunol Cell Biol. 2000]
New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis complex.
Collins DM. Immunol Cell Biol. 2000 Aug; 78(4):342-8.

See reviews... See all...

Cited by 3 PubMed Central articles

A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. [Infect Immun. 2008]
A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG.
Tullius MV, Harth G, Maslesa-Galic S, Dillon BJ, Horwitz MA. Infect Immun. 2008 Nov; 76(11):5200-14. Epub 2008 Aug 25.
Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage. [Genet Vaccines Ther. 2007]
Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage.
Pelizon AC, Martins DR, Zorzella SF, Trombone AP, Lorenzi JC, Carvalho RF, Brandão IT, Coelho-Castelo AA, Silva CL, Sartori A. Genet Vaccines Ther. 2007 Nov 29; 5:12. Epub 2007 Nov 29.
Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes. [Clin Exp Immunol. 2005]
Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes.
Hammond AS, Klein MR, Corrah T, Fox A, Jaye A, McAdam KP, Brookes RH. Clin Exp Immunol. 2005 Apr; 140(1):109-16.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A novel TB vaccine; towards a strategy based on our understanding of BCG failure...
A novel TB vaccine; towards a strategy based on our understanding of BCG failure.
Vaccine. 2002 Nov 22 ;21(1-2):7-14.

PubMed
The regulation of HIV-1 gene expression: the emerging role of chromatin.
The regulation of HIV-1 gene expression: the emerging role of chromatin.
DNA Cell Biol. 2002 Oct ;21(10):697-705.

PubMed
Measurement of the CP asymmetry amplitude sin2beta with B0 mesons.
Measurement of the CP asymmetry amplitude sin2beta with B0 mesons.
Phys Rev Lett. 2002 Nov 11 ;89(20):201802. Epub 2002 Oct 29 .

PubMed
Robustness of the in-degree exponent for the World-Wide Web.
Robustness of the in-degree exponent for the World-Wide Web.
Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Oct ;66(4 Pt 2):046107. Epub 2002 Oct 10 .

PubMed
Aging changes in the human aortic valve in relation to dystrophic calcification.
Aging changes in the human aortic valve in relation to dystrophic calcification.
Hum Pathol. 1976 Jan ;7(1):47-60.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information